cancer clinical trials in sugar land, TX

Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Breast Cancer

PhII ICb With/Without Erbitux in MBC Pts

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Metastatic Breast Cancer

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

B-Cell Chronic Lymphocytic Leukemia

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Prostate Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Prostate Cancer

Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Anal Cancer

Adj TC + Herceptin Early Stage Breast Cancer

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Breast Cancer

TAC Versus TC for Adjuvant Breast Cancer

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Breast Cancer

Pre-op Rectal ChemoRad +/- Cetuximab

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Rectal Cancer

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Lung Cancer, Radiation Toxicity

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Prostate Cancer

Phase II Sunitinib Prog Met AIPC

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Metastatic Prostate Cancer

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Esophageal Cancer

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Androgen-independent Prostate Cancer

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Endometrial Cancer, Fatigue, Neurotoxicity

Gemzar, Cisp, Sunitinib Urothelial Ca

Texas Oncology Cancer Center - Sugar Land
Sugar Land, Texas 77479

Urothelial Cancer

Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study

Teva Investigational Site 166
Sugar Land, Texas

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Texas Oncology Cancer Center - Sugar Land
Sugar Land, Texas 77479

Breast Cancer

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Prostate Cancer, Sexual Dysfunction

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Prostate Cancer

Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Head and Neck Cancer

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery

Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer

Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Lung Cancer

Ixabepilone + Carboplatin Metastatic Breast Cancer

Texas Oncology - Sugar Land
Sugar Land, Texas 77479

Metastatic Breast Cancer

Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Cognitive/Functional Effects, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer

Texas Oncology - Sugar Land
Sugar Land, Texas 77479

Breast Cancer

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer

Texas Oncology - Sugar Land
Sugar Land, Texas 77479

Advanced Prostate Cancer, Prostatic Neoplasms

Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery

Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Breast Cancer

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor

Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

Biopharma Research Associates
Sugar Land, Texas 77479

Low Back Pain, Migraine, Diabetic Neuropathies, Osteoarthritis

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Texas Oncology Cancer Center--Sugar Land
Sugar Land, Texas 77479

Carcinoma, Non-Small Cell Lung

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Colorectal Cancer Metastatic

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Prostate Cancer

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Texas Oncology Cancer Center--Sugar Land
Sugar Land, Texas 77479

Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Texas Oncology Cancer Center-Sugar Land
Sugar Land, Texas 77479

Metastatic Breast Cancer

Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
Sugar Land, Texas 77479

Brain and Central Nervous System Tumors

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

Texas Oncology Cancer Center - Sugar Land
Sugar Land, Texas 77479

Metastatic Breast Cancer

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

Investigational Site Number 840035
Sugar Land, Texas 77055

Venous Thromboembolism, Cancer

Join the directory

Join the Community

Join the Directory